Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 576: 100-107, 2021 10 22.
Article in English | MEDLINE | ID: mdl-34482022

ABSTRACT

RATIONALE: Coronary artery ligation to induce myocardial infarction (MI) and ischemia injury in mice is typically performed in normal mice, but This is not consistent with disease progression. There should be atherosclerosis (AS) first, followed by MI. OBJECTIVE: We tried a novel model to induce MI that was established on atherosclerosis in mice. This approach was much more consistent with disease progression. METHODS: In this study, Mice lacking apolipoprotein E (ApoE-/-) were randomly divided into four groups. The mice of the control and MI groups were fed normal diet for 24-weeks, while the mice of AS and AS + MI groups were fed high-fat diet (HFD). After 23 weeks, the mice of MI and AS + MI groups were ligated with coronary arteries. A week later, after echocardiography, analysis of plaque and myocardium were conducted on aortic and heart, then the serum, aorta and heart tissues were further detected. RESULTS: Our results showed that AS model mice exhibited significant body weight gain, dyslipidemia and atherosclerotic lesions formation which were in accordance with the pathological changes of AS. Co-treatment with AS and MI led to higher operative mortality and heart pathological were in accordance with the pathological changes of MI. In addition, Echocardiography and NT pro-BNP revealed co-treatment with AS and MI led to deterioration of cardiac function. AS also aggravated myocardial inflammatory cell infiltration and fibrosis post-MI. CONCLUSIONS: Together, it is feasible to establish myocardial infarction model based on atherosclerosis model.


Subject(s)
Atherosclerosis/pathology , Diet, High-Fat , Disease Models, Animal , Dyslipidemias/physiopathology , Mice, Knockout, ApoE/genetics , Myocardial Infarction/pathology , Animals , Atherosclerosis/metabolism , Disease Progression , Female , Mice , Mice, Inbred C57BL , Mice, Knockout, ApoE/metabolism , Myocardial Infarction/metabolism
2.
Free Radic Biol Med ; 130: 348-360, 2019 01.
Article in English | MEDLINE | ID: mdl-30395970

ABSTRACT

The events that trigger early onset of atherosclerotic lesion formation are poorly understood. Initially, microscopic atherosclerotic lesions appear in the aortic root in 10-week-old apoE-knockout mice that are fed normal chow. Using proteome and immunohistochemical analyses, we investigated proteins in aortic media whose expression changes in athero-prone regions at the beginning of lesion formation. Protein profiles of the root/arch and thoracic/abdominal regions of aortas in 10-week-old apoE-knockout mice were analyzed using 2D-gel electrophoresis. Proteins in 81 spots with different abundance were identified. Among them, we focused on proteins related to oxidative stress and smooth muscle cells (SMCs). The level of peroxiredoxin 2 (Prx2), a major cellular antioxidant enzyme that reduces hydrogen peroxide, was lower in aortic root/arch compared with thoracic/abdominal aorta. Immunohistochemical staining demonstrated that Prx2 expression in SMCs in the aortic root was high at 4 weeks and decreased at 10 weeks in apoE-knockout mice, while Prx2 expression in the aorta was unchanged in wild-type mice. The level of Prx2 expression correlated positively with the SMC differentiation markers, α-smooth muscle actin and transgelin, suggesting that a decline in Prx2 expression accompanies SMC dedifferentiation. Accumulated acrolein-modified proteins and the infiltration of macrophages in aortic media were observed in areas with low Prx2 expression. These results showed that Prx2 expression declines in athero-prone aortic root before lesion formation, and this reduction in Prx2 expression correlates with lipid peroxidation, SMC dedifferentiation, and macrophage recruitment.


Subject(s)
Aorta/metabolism , Atherosclerosis/drug therapy , Myocytes, Smooth Muscle/metabolism , Oxidative Stress/drug effects , Peroxiredoxins/genetics , Acrolein/pharmacology , Actins/genetics , Animals , Aorta/pathology , Atherosclerosis/genetics , Atherosclerosis/pathology , Cell Dedifferentiation/genetics , Gene Expression Regulation/genetics , Humans , Hydrogen Peroxide/metabolism , Macrophages/metabolism , Mice , Mice, Knockout, ApoE/genetics , Microfilament Proteins/genetics , Muscle Proteins/genetics , Myocytes, Smooth Muscle/drug effects , Oxidative Stress/genetics
3.
Am J Physiol Endocrinol Metab ; 315(2): E218-E228, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29462565

ABSTRACT

PycnogenolR (PYC), a combination of active flavonoids derived from French maritime pine bark, is a natural antioxidant that has various pharmacological activities. Here, we investigated the beneficial effect of PYC on diet-induced hepatic steatosis. Apolipoprotein E (ApoE)-deficient male mice were administered PYC at oral doses of 30 or 100 mg·kg-1·day-1 for 2 wk in advance and were then fed a high-cholesterol and -fat diet (HCD) for 8 wk. Biochemical, immunohistochemical, and gene expression analyses were conducted to explore the effect of PYC on lipid metabolism in ApoE-deficient mice on a HCD. Short-term treatment with HCD in ApoE-deficient mice induced hepatic injuries, such as lipid metabolism disorder and hepatic histopathological changes. We found that PYC reduced body weight and the increase of serum lipids that had been caused by HCD. Supplementation of PYC significantly reduced lipid deposition in the liver, as shown by the lowered hepatic lipid content and histopathological lesions. We subsequently detected genes related to lipid metabolism and inflammatory cytokines. The study showed that PYC markedly suppressed the expression of genes related to hepatic lipogenesis, fatty acid uptake, and lipid storage while increasing the lipolytic gene, which thus reduced hepatic lipid content. Furthermore, PYC mainly reduced the expression of inflammatory cytokines and the infiltration of inflammatory cells, which were resistant to the development of hepatic steatosis. These results demonstrate that PYC protects against the occurrence and development of hepatic steatosis and may provide a new prophylactic approach for nonalcoholic fatty liver disease (NAFLD).


Subject(s)
Antioxidants/pharmacology , Diet , Flavonoids/pharmacology , Mice, Knockout, ApoE/physiology , Non-alcoholic Fatty Liver Disease/prevention & control , Plant Extracts/pharmacology , Animals , Body Weight/drug effects , Body Weight/genetics , Cytokines/biosynthesis , Cytokines/genetics , Lipid Metabolism/drug effects , Lipid Metabolism/genetics , Lipids/blood , Male , Mice , Mice, Knockout , Mice, Knockout, ApoE/genetics , Non-alcoholic Fatty Liver Disease/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...